Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

e0618 Effects of Rosuvastatin on plasma NO and ET-1 during myocardial ischaemia-reperfusion injury in rabbits

View through CrossRef
Objective To study the change of endothelial function during myocardial ischaemia-reperfusion injury in rabbits and the effect of Rosuvastatin. Methods 16 New Zealand rabbits were randomLy divided into two groups: ischaemia/reperfusion injury group (control group) and Rosuvastatin group (drug group). Establish the myocardial ischaemia-reperfusion model. The camponotus upward elevation (≥0.2 mv) of the ST segment shown by the ECG indicated the successful ligation of the left anterior descending coronary artery; 40 mins later the ligation line was cut off, and the ST segment of ECG returned to 1/2 or more, which showed the success of reperfusion. At the four time points, before occlusion, 40 min after occlusion, 60 mins and 180 mins after reperfusion. We measured rabbit serum nitric oxide (NO), plasma endothelia-1 (ET-1) content. SPSS 11.5 software was applied, using ANOVA to p <0.05 for differences with statistical significance. Results In both groups, the serum NO content reduced gradually and the plasma ET-1 content increased gradually with protraction of the ischaemia and reperfusion time. Before ischaemia the serum NO[(109.875±32.255) μmol/l vs (114.500±37.405) μmol/l, p>0.05] and plasma ET-1 [(221.111±28.125) pg/ml vs (204.594±31.790) pg/ml, p>0.05], have no significant difference between the groups. At other three time points, the increased serum NO content [(63.125±18.962), (43.500±16.518), (29.625±14.162) μmol/l vs (82.000±13.825), (63.375±17.541), (50.250±18.987) μmol/l, p<0.05] in drug group was markedly lower than that in the control group and the reduced plasma ET-1 content [(331.785±35.341), (375.914±45.204), (459.829±70.110) pg/ml vs (282.541±38.928), (315.152±55.263), (377.795±60.427) pg/ml, p<0.05] in drug group was markedly higher than those in the control group. Conclusions Through increasing serum NO, and reducing plasma ET-1, rosuvastatin can improve endothelial function in myocardial ischaemia-reperfusion injury rabbits.
Title: e0618 Effects of Rosuvastatin on plasma NO and ET-1 during myocardial ischaemia-reperfusion injury in rabbits
Description:
Objective To study the change of endothelial function during myocardial ischaemia-reperfusion injury in rabbits and the effect of Rosuvastatin.
Methods 16 New Zealand rabbits were randomLy divided into two groups: ischaemia/reperfusion injury group (control group) and Rosuvastatin group (drug group).
Establish the myocardial ischaemia-reperfusion model.
The camponotus upward elevation (≥0.
2 mv) of the ST segment shown by the ECG indicated the successful ligation of the left anterior descending coronary artery; 40 mins later the ligation line was cut off, and the ST segment of ECG returned to 1/2 or more, which showed the success of reperfusion.
At the four time points, before occlusion, 40 min after occlusion, 60 mins and 180 mins after reperfusion.
We measured rabbit serum nitric oxide (NO), plasma endothelia-1 (ET-1) content.
SPSS 11.
5 software was applied, using ANOVA to p <0.
05 for differences with statistical significance.
Results In both groups, the serum NO content reduced gradually and the plasma ET-1 content increased gradually with protraction of the ischaemia and reperfusion time.
Before ischaemia the serum NO[(109.
875±32.
255) μmol/l vs (114.
500±37.
405) μmol/l, p>0.
05] and plasma ET-1 [(221.
111±28.
125) pg/ml vs (204.
594±31.
790) pg/ml, p>0.
05], have no significant difference between the groups.
At other three time points, the increased serum NO content [(63.
125±18.
962), (43.
500±16.
518), (29.
625±14.
162) μmol/l vs (82.
000±13.
825), (63.
375±17.
541), (50.
250±18.
987) μmol/l, p<0.
05] in drug group was markedly lower than that in the control group and the reduced plasma ET-1 content [(331.
785±35.
341), (375.
914±45.
204), (459.
829±70.
110) pg/ml vs (282.
541±38.
928), (315.
152±55.
263), (377.
795±60.
427) pg/ml, p<0.
05] in drug group was markedly higher than those in the control group.
Conclusions Through increasing serum NO, and reducing plasma ET-1, rosuvastatin can improve endothelial function in myocardial ischaemia-reperfusion injury rabbits.

Related Results

Rosuvastatin Alone or With Extended‐Release Niacin: A New Therapeutic Option for Patients With Combined Hyperlipidemia
Rosuvastatin Alone or With Extended‐Release Niacin: A New Therapeutic Option for Patients With Combined Hyperlipidemia
Combination therapy with a statin and niacin may provide optimal therapy for patients with combined hyperlipidemia and low levels of highdensity lipoprotein (HDL) cholesterol. The ...
e0141 The effects and mechanisms between DIDS and EDRV on acute ischaemia-reperfusion injury myocardium
e0141 The effects and mechanisms between DIDS and EDRV on acute ischaemia-reperfusion injury myocardium
Aim To investigate the effects and Mechanisms of chloride channel inhibitor, 4, 4′- Diisothiocyanostilbene-2, 2′- disulfonic acid (DIDS) and free radical scavenge...
e0028 The effect of acute activation of ALDH2 on myocardial ischaemia/reperfusion injury in rat
e0028 The effect of acute activation of ALDH2 on myocardial ischaemia/reperfusion injury in rat
Background Our previous study combined several animal experiments conducted recently showed aldehyde dehydrogenase-2 (ALDH2) was correlated with myocardial ischae...
Entanglement of AGE-RAGE axis in cardiac pathosis
Entanglement of AGE-RAGE axis in cardiac pathosis
AbstractCardiovascular diseases are the major cause of death globally. Acute coronary syndrome is one of numerous cardiovascular illnesses, including advanced glycation end product...
GW24-e3829 The role of CD59 in mouse cerebral ischaemia-reperfusion injury
GW24-e3829 The role of CD59 in mouse cerebral ischaemia-reperfusion injury
Objectives To investigate dynamic changes of complement regulatory protein CD59 expression and discuss its possible mechanisms. During cerebral ischaemia-reperfus...
TETRANDRINE CONTROL PRO-INFLAMMATORY FACTOR TO REDUCE RAT MYOCARDIAL ISCHAEMIC/REPERFUSION INJURY
TETRANDRINE CONTROL PRO-INFLAMMATORY FACTOR TO REDUCE RAT MYOCARDIAL ISCHAEMIC/REPERFUSION INJURY
Objectives To investigate how tetrandrine through regulate the pro-inflammation factors TNF-α, IL-1β, IL-6 to attenuate rat ischaemic/reperfusion injury. ...
Quantification of tissue damage in the feline small intestine during ischaemia‐reperfusion: the importance of free radicals
Quantification of tissue damage in the feline small intestine during ischaemia‐reperfusion: the importance of free radicals
Intestinal ischaemia is accompanied by characteristic mucosal lesions, which can be graded according to a six‐grade system proposed by Chiu et al. (1970). This report describes a c...

Back to Top